IFNA1 and infection: While exogenous IFN-α administration exerts a clear antiviral effect in vivo in both pathogenic and non-pathogenic infections [12]–[14], an elevated type I IFN response has also been proposed as an immunopathogenic mechanism [15]–[17] and reported as a marker of poor immunologic response to antiretroviral therapy [18].